At the BIO CEO & Investor Digital Conference, taking place February 16-18, 2021, you will hear key biotech and pharma leaders discuss the most pertinent industry trends, the market outlook, and best practices for executive leadership. 

#BIOCEO21 topics include:
  • Progress in Drugging the Undruggable Cancer Targets
  • SPACs: Criteria for Successful Launches
  • Reverse Trend: China’s Shift to a Center for Innovation
  • Deal Making in the Next Decade: Lessons Learned and Planning for Tomorrow
  • CRISPR’s Progress for Patients: Clinical Development of Therapies
  • Policy Scenarios on Investor’s Reactions to Reference Pricing Models
  • Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in the Congress and White House
  • Turning RNA Research into Medicines
  • Market Outlook: Breaking Records or Expecting an Adjustment